Loading
Loading…
Loading…
| # | Company | Rank | Status |
|---|---|---|---|
| 1 | NAAccepted-Finance | NA | Accepted-Finance As per Annexure |
| 2 | NAAccepted-Finance 4TH FLOOR B WING ZYDUS CORPORATE PARK SCHEME NO 63 SURVEY NO 536 SARKHEJ GANDHINAGAR HIGHWAY AHMEDABAD GUJARAT 382481 | AHMADABAD | GUJARAT | 382481 | NA | Accepted-Finance As per Annexure |
| 3 | NAAccepted-Finance CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | NA | Accepted-Finance As per Annexure |
| 4 | NAAccepted-Finance 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | NA | Accepted-Finance As per Annexure |
| 5 | NAAccepted-Finance | NA | Accepted-Finance As per Annexure |
Tender Value
Refer Docs
Closing Date
12 Dec 2019, 6:00 pmClosed
MD OSMCL
O/o the Odisha State Medical Corporation Ltd.,In front of Ram Mandir, Convent Square, Unit III, Bhubaneswar
Supply of Anti Cancer Drugs, Medical Consumables
2019_OSMCL_57252_1
OSMCL/2019-20/DRUGS- DHS-ACD-GR-III/05
National Competitive Bid
Medicines
Item Rate
70 days
OSMCL Bhubaneswar
Please refer Tender documents
3 documents required · 3 mandatory
₹5,600
Yes
Odisha State Medical Corporation Ltd.
Exempted
Tender Hall of OSMCL, Bhubaneswar
29 Jan 2020
15 Nov 2019
20 Dec 2019
15 Nov 2019
12 Dec 2019
28 Nov 2019
22 Nov 2019
Cap. Lenalidomide, 10mg/ Cap
Cap. Lenalidomide, 5mg/ Cap
Cap. Temozolamide, 100mg/ Cap
Cap. Temozolamide, 20mg / Cap
Cap. Temozolamide, 250mg/ Cap
Cap. Thalidomide, 100mg / Cap
Inj. 5 Fluorouracil, 250 mg / 5ml
Inj. 5 Fluorouracil, 500 mg / 5ml
Inj. Bendamustine, 100mg
Inj. Bleomycin (with diluents in plastic container), 15 mg/vial
Inj. Bortezomib, 2mg / Vial
Inj. Carboplatin, 10 mg / ml
Inj. Carboplatin, 10 mg / ml
Inj. Cisplatin, 10 mg/Vial
Inj. Cisplatin, 50 mg / vial
Inj. Cyclophosphamide, 200mg/Vial
Inj. Cyclophosphamide, 1gm/Vial
Inj. Dacarbazine, 200mg / Vial
Inj. Dacarbazine, 500mg/ Vial
Inj. Decitabine, 50mg / Vial
Inj. Docetaxel, 20mg / Vial
Inj. Daunorubicin, 20mg/vial
Inj. Docetaxel, 80mg / Vial
Inj. Docetaxel, 120 mg / Vial
Inj. Epirubicin, 10mg / Vial
Inj. Epirubicin, 50mg / Vial
Inj. Epirubicin, 100mg / Vial
Inj. Etoposide (with diluents in plastic container), 100mg/Vial
Inj. Filgrastim pfs, 300mcg/ pfs
Inj. Filgrastim, 300mcg/ Vial
Inj. Filgrastim peg, 6mg/ PFS
Inj. Gemciatbine (with diluents in plastic container), 200mg/vial
Inj. Gemciatbine (with diluents in plastic container), 1gm/vial
Inj. Ifosfamide with Mesna, 1gm/vial
Inj. L-Asperginase (Powder form)(with diluents in plastic container), 10,000 IU / Vial
Inj. L-Asperginase (Powder form) (with diluents in plastic container), 5,000 IU / Vial
Inj. Leucovorin Calcium, 50mg / 5ml
Inj. Leucovorin Calcium, 15mg / 2ml
Inj. Methotrexate, 50 mg / Vial
Tab./Cap. Nilotinib (Aluminium foil/Blister pack), 200 mg/Tab./Cap
Inj. Oxaliplatin, 50 mg / Vial
Inj. Oxaliplatin, 100 mg / Vial
Inj. Paclitaxel (with transfusion set (PVC and DEHP free) and NS Glass Bottle of 500 ml./ Polyethylene (PVC and DEHP free) 500 ml bottle ), 100 mg / Vial
Inj. Paclitaxel (with transfusion set (PVC and DEHP free) and NS Glass Bottle of 500 ml./ Polyethylene(PVC and DEHP free) 500 ml bottle ), 300 mg / Vial
Inj. Paclitaxel (with transfusion set (PVC and DEHP free) and NS Glass Bottle of 500 ml./ Polyethylene(PVC and DEHP free) 500 ml bottle ), 260/250 mg /vial
Inj. Rituximab, 100 mg / Vial
Inj. Rituximab, 500 mg / Vial
Inj. Trastuzumab, 440 mg
Inj. Vinorelbine, 10 mg / Vial
Inj. Vinblastine, 10 mg / Vial
Inj. Vincristine Sulphate, 1mg / ml
Inj. Vincristine Sulphate, 2mg / ml
Inj. Zoledronic Acid, 4 mg / Vial
Tab. Cyclosporine, 50mg
Inj. Azacitidine, 100 mg/Vial
Tab Anastrozole, 1 Mg
Tab. Bicalutamide, 50mg/Tab
Tab. Capecitabine, 500mg/ Tab
Inj. Cytarabine, 100mg 5ml / vial
Inj. Cytarabine, 1GM / VIAL
Inj. Cytarabine, 500mg 5ml/ Vial
Tab. Erlotinib, 150mg/ Tab
Tab. Gefitinib, 250mg/ Tab
Tab. Ibandronic acid, 50mg/ Tab
Tab./ Cap Imatinib (Aluminium foil/ Blister pack), 100 mg/Tab./Cap
Tab. Imatinib(Aluminium foil/ Blister pack), 400 mg/Tab
Tab. Letrozole, 2.5mg/ Tab
Tab. Sorafenib, 200mg/ Tab
Inj. Methotrexate, 25 mg/ml (LRC)
Inj. Mesna, 200 mg
Inj. Doxorubicin HCl, 2mg/ ml
Inj. Pemetrexed, 500 mg / Vial
Inj. Pemetrexed, 100 mg / Vial
Tab. Pazopanib, 200mg/ Tab
Inj. Doxorubicin liposomal, 20 mg / Vial
Tab. Tamoxifen, 10 mg
Tab. Tamoxifen, 20 mg
Inj. Actinomycin D, 500 mcg / Vial
Inj. Doxorubicin HCl, 2 mg / ml
Tab. Eltrombopag (Aluminium foil/Blister pack), 25 mg/Tab
inj. Interferon L-2B, 10 million IU/Vail
Inj. Lapatinib, 250 mg
Tab. Abiraterone, 250 mg
Inj. Denasumab, 120mg
inj. Irinotecan, 100 mg
inj. Nab- Pclitaxel, 100 mg
Buprenorphine Patch, 5 mg
Buprenorphine Patch, 10 mg
Tab. Morphine Sulphate CR, 30 mg/Tab.
Tab Aprepetant, Each Kit contain ( 125 mg - 1 Tab. And 80 mg - 2 Tab.)
Cipla Ltd
RUSAN PHARMA LTD
Glenmark Pharmaceuticals Ltd.
Novartis Healthcare Pvt. Ltd.
GLS PHARMA LTD.
BDR Pharmaceuticals International Pvt. Ltd.
NATCO PHARMA LIMITED
Fresenius Kabi Oncology Limited
M/s Hetero Bio Pharma Ltd
Naprod Life Sciences Pvt. Ltd.
Getwell Pharmaceuticals
Cadila Healthcare ltd
Reliance Life Sciences Pvt. Ltd.
Intas Pharmaceuticals Ltd
Dr. Reddys Laboratories Limited
NATCO PHARMA LIMITED
Intas Pharmaceuticals Ltd
Naprod Life Sciences Pvt. Ltd.
Cadila Healthcare ltd
Dr. Reddys Laboratories Limited
M/s Hetero Bio Pharma Ltd
Getwell Pharmaceuticals
GLS PHARMA LTD.
JODAS EXPOIM PRIVATE LIMITED
RUSAN PHARMA LTD
Glenmark Pharmaceuticals Ltd.
BDR Pharmaceuticals International Pvt. Ltd.
Fresenius Kabi Oncology Limited
stage.html
html • 0.08 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .